International Stem Cell Corporation’s Human Parthenogenetic Stem Cells To Be Used In Germany In The Development Of Treatments For Neural Disease
Monday, March 3rd, 2008International Stem Cell Corporation (OTCBB:ISCO) announced that its human parthenogenetic stem cell lines will be used in Germany in studies aimed at creating specific cell types to treat human neural diseases such as Parkinson's disease. The work will be headed by Dr. Albrecht Mueller of the University of Wuerzburg, Wuerzburg, Germany ...